These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure. Kocabas S; Yedicocuklu D; Askar FZ Eur J Anaesthesiol; 2008 Nov; 25(11):940-6. PubMed ID: 18538050 [TBL] [Abstract][Full Text] [Related]
28. Analysis of the pharmacodynamic parameters in a model for neuromuscular block. Nigrovic V; Anton A; Bengez R Med Sci Monit; 2004 Dec; 10(12):BR468-76. PubMed ID: 15567978 [TBL] [Abstract][Full Text] [Related]
29. Role of muscle relaxants in pediatric anesthesia. Meakin GH Curr Opin Anaesthesiol; 2007 Jun; 20(3):227-31. PubMed ID: 17479026 [TBL] [Abstract][Full Text] [Related]
30. [Prolonged paralysis after long-term administration of vecuronium in the intensive care unit]. Tanaka O; Akai H; Takekida S; Tanaka Y; Wake M; Iijima K; Horikawa Y; Ijichi K Masui; 2006 Aug; 55(8):992-4. PubMed ID: 16910480 [TBL] [Abstract][Full Text] [Related]
31. [Neuromuscular monitoring in a patient with hemiparesis. Resistance of the paralysed musculature to non-depolarising muscle relaxants]. Müller R; Knüttgen D; Vorweg M; Doehn M Anaesthesist; 2002 Aug; 51(8):644-9. PubMed ID: 12391524 [TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure. Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664 [TBL] [Abstract][Full Text] [Related]
33. [Advantages and disadvantages of the use of the newer muscle relaxants for anesthesia induction]. Diefenbach C; Buzello W Klin Anasthesiol Intensivther; 1993; 44():88-97; discussion 108-13. PubMed ID: 8510441 [No Abstract] [Full Text] [Related]
38. [The use of muscle relaxants for routine induction of anesthesia in Germany]. Geldner G; Fuchs-Buder T; Hofmockel R; Diefenbach C; Ulm K; Blobner M Anaesthesist; 2003 May; 52(5):435-41. PubMed ID: 12750828 [TBL] [Abstract][Full Text] [Related]
39. Sugammadex: a novel agent for the reversal of neuromuscular blockade. Nicholson WT; Sprung J; Jankowski CJ Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516 [TBL] [Abstract][Full Text] [Related]
40. Short use of muscle relaxants following single stage laryngotracheoplasty in children. Roeleveld PP; Hoeve LJ; Joosten KF; de Hoog M Int J Pediatr Otorhinolaryngol; 2005 Jun; 69(6):751-5. PubMed ID: 15885327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]